MV Health Professional

Professional/For your practice/Health systems & enterprise

Health systems · Payers · Employee benefits

Specialist devices.Institutional reach.

Bring a practical, home-use device option into sexual- and pelvic-health care. MV Health combines six adaptable designs, published research and patient resources with a partnership shaped around your population.

Discuss a partnership Prepare your review
Six device designs · Model-specific evidence · Professional resourcesExplore the portfolio

Three perspectives. A shared opportunity.

Make the offer fit the people you serve.

Give patients and members a clear way to explore device options, with information they can use and support they can find. Choose the partnership route that fits your organization.

01 / Clinical pathways

Health systems & academic centers

Add a device discussion to an existing service line, with one clinical sponsor and a clear route from selection to supply.

  • Start with urology and erectile-function care, or a clinical review of sexual- and pelvic-health research.
  • Connect procurement with patient education, product support and your existing follow-up.
  • Evaluate one defined population before expanding across sites.

Women’s health, oncology survivorship, menopause and maternity teams can review the relevant studies. A life stage alone does not establish device suitability; use the exact model’s documentation and clinical assessment.

See practice pathways

02 / Population value

Payers & value-based care

Explore whether a defined device pathway can add useful choice for members. Build the business case around your population and the care they actually receive.

  • Review evidence for the proposed model and patient group.
  • Discuss a funded evaluation, provider-led pathway or member purchasing route.
  • Assess outcomes alongside device, delivery, support and clinical-service costs.

Cost savings, reduced utilization and comparative effectiveness need a suitable evaluation. A device’s purchase price alone does not establish those outcomes or a coverage policy.

Plan the evaluation

03 / Member experience

Employers & benefit platforms

Bring sexual and pelvic health into a broader member-support conversation. Explore device access alongside your existing men’s health, women’s health or specialist-care benefit.

  • Consider a member-paid offer, employer contribution or defined program budget.
  • Make eligibility, member costs and the support route easy to understand.
  • Plan private communications and appropriate clinical referral.

Confirm HSA/FSA eligibility for the exact item and circumstances with the plan administrator. HSA/FSA payment and insurance coverage are separate questions.

Review benefit-account guidance (opens in a new tab)

The complete portfolio

Different needs. Thoughtful design.

Compare the form factors, then review the evidence and current intended use for the exact model. Research topics below describe areas of study, not a portfolio-wide treatment claim.

Tenuto 2 device illustration

Wearable · Penis & perineum

Tenuto 2

A wearable option for erectile dysfunction. Research includes psychogenic ED and rehabilitation after prostate cancer treatment, including combined-care protocols.

Explore Tenuto 2
Tenuto Mini device illustration

Compact wearable

Tenuto Mini

A compact erectile-function design. Published preliminary research focuses on psychogenic and situational erectile dysfunction.

Explore Tenuto Mini
Molto device illustration

Slim · Malleable insert

Molto

A slim, adaptable form factor. Early research explores chronic prostatitis, pelvic pain and delayed ejaculation; study designs include small cohorts and case reports.

Explore Molto
Crescendo 2 device illustration

Flexible · Targeted contact

Crescendo 2

An adjustable design for targeted contact. The Crescendo research family includes pelvic pain, arousal and orgasm studies; distinguish model generations in each publication.

Explore Crescendo 2
Poco device illustration

Compact · Bendable design

Poco

A compact design in MV’s pelvic-health research portfolio, including randomized sexual-function research and a feasibility study alongside usual vaginismus care.

Explore Poco
Legato device illustration

External · Distributed contact

Legato

A design for distributed external stimulation. Published research explores arousal and lubrication; review the studied population and model-specific information.

Explore Legato

Published research

Give the clinical committee something concrete.

Start with original publications, not a single portfolio-wide efficacy percentage. These studies address different clinical questions; none establishes the return on investment of an institutional program.

Randomized controlled trial / 2026

Sexual & pelvic health

84participants randomized · 8 weeks

Scheduled device use with an educational handout was compared with the handout alone. The journal report found better sexual-function scores in the device group.

Single-center, unblinded trial; 81 completed. MV identifies the model as Poco; the abstract does not name it. The report updates the earlier conference report. PubMed lists Mystery Vibe / Brandow Research Grant funding.

Read the trial (opens in a new tab)

Controlled feasibility pilot / 2025

Poco alongside usual care

19participants analysed · 30 enrolled

A non-randomized psychosexual-service pilot explored adding Poco to usual care, including vaginal dilator therapy. Nine of ten participants in the device group rated it mostly or completely acceptable.

An acceptability and feasibility study, not a definitive efficacy trial. Attrition and the combined-care approach matter when interpreting the findings.

Read the pilot study (opens in a new tab)

Preliminary journal report / 2025

Tenuto Mini & psychogenic ED

30men studied · 8 weeks

An uncontrolled preliminary study reported improved erectile-function questionnaire scores after home use of Tenuto Mini in men with psychogenic erectile dysfunction.

Published as correspondence. No control group; the principal author disclosed a consultancy relationship and devices were supplied at no cost.

Read the preliminary report (opens in a new tab)
Explore the evidence library

The commercial conversation

Build the budget around the whole pathway.

Device supply, care delivery and benefit funding are different parts of the model. Agree each explicitly so clinical and financial teams are working from the same assumptions.

Device supply

Request a current quote for your models, volume and delivery locations. Discuss direct purchasing or a distributor route, then confirm the seller, availability, shipping, returns and warranty terms.

Include implementation time and support costs in the budget, not just the unit price.

Explore ordering

Program & member funding

Decide whether the organization funds the device, contributes towards it or offers a member-paid purchasing route. Make any member charges and eligibility rules clear before enrollment.

For a payer business case, define the comparator, analysis period and total costs. Do not assume device use replaces medication, therapy or procedures.

Define the value measures

Optional HealthArc program

Scope HealthArc as a separate monitoring option alongside device supply. MV.Health supplies the selected device. HealthArc supports enrollment, patient-reported check-ins, care management and documentation. Your practice retains the care plan, clinical oversight and responsibility for eligible claims.

MV devices and the MV app do not collect usage telemetry. Review clinical fit, the monitoring setup, provider eligibility, patient costs and payer rules before enrollment. Reimbursement is not guaranteed.

Review the HealthArc program and eligibility.

Request a HealthArc introduction

From first conversation to first cohort

A clear route into care.

Start with a defined population and a useful decision to inform. Match the pace of the evaluation to clinical governance and operational readiness.

01

Scope the fit

Name a clinical sponsor. Define the patient group, exact models, eligibility and the evidence relevant to the proposed use. Include procurement and compliance early.

02

Agree the offer

Confirm purchasing, member costs, supply arrangements and support ownership. Map any data sharing and monitoring before selecting the delivery model.

03

Prepare the people

Review model-specific guides with staff. Agree patient education, consent, clinical escalation and the hand-off for product questions.

04

Review & decide

Use the measures and review dates agreed before launch. Document what worked, what needs changing and whether there is a case to expand.

Define success before enrollment

Measure value, not just uptake.

Choose a small, relevant set of measures with your clinical and evaluation teams. Set the sample size, comparator and follow-up period to answer the question—not an arbitrary rollout target.

01 / Clinical team

Clinical outcomes

Select a validated measure appropriate to the population and proposed use. Agree baseline and follow-up, and account for other treatments and incomplete follow-up.

02 / Experience team

Member experience

Review acceptability, ease of setup, comfort and access to help. Include people who stop using the device, not only those who complete the program.

03 / Operations

Operational fit

Track time to delivery, onboarding completion, product questions and clinical escalations. Identify the workload for each team.

04 / Finance & analytics

Economic value

Measure the full cost per participant. Assess utilization or claims only with an appropriate comparison, data access and analysis plan.

Operational feasibility is not the same as clinical effectiveness or cost savings. A formal research study may require separate ethics review, registration and analysis planning.

Discuss an evaluation

Prepare your institutional review

The right information. The right people.

Share the source documents with the colleagues who will make the decision. Request any additional model-specific or supplier documentation through our team.

Institutional pilot brief

Bring a shared two-page framework to your first review: population, model, clinical owner, optional monitoring, outcomes, budget and decision criteria.

A planning resource, not a validated protocol, partner commitment or coverage decision.

Download the pilot brief (PDF)

Explore MV’s design and business recognition, or hear clinicians discuss devices in their own words.

Awards & recognitions

Before we begin

Questions from your committee.

Clear answers for clinical, procurement, payer and benefits teams.

Where is a sensible first evaluation?

Choose one population with a named clinical lead. Erectile-function care is a practical starting conversation for urology teams. Sexual- and pelvic-health services should review the relevant research and exact model documentation. Postpartum status, menopause or a history of cancer does not by itself establish that a device is appropriate.

Can we offer the devices as an employee or member benefit?

Discuss a member-paid route, an employer contribution or a funded program. The offer must define eligibility, patient information, privacy, support and any clinical referral. Confirm HSA/FSA requirements for the exact item with the administrator; an employer-funded benefit does not establish insurance coverage.

Does a partnership include monitoring or reimbursement?

Not automatically. Device purchasing can be scoped without monitoring. HealthArc is an available operating program, with its own practice agreement, patient-reported check-ins, clinical oversight and billing review. Confirm platform suitability, patient costs and payer requirements; no institution-wide coverage or reimbursement is implied.

What pricing, delivery and onboarding can we expect?

Request a proposal for the exact models, volumes and locations. Direct delivery, distributor routing, packaging, co-branding, staff preparation and service levels are items to agree—not standard commitments assumed by this page.

What information should we share first?

Tell us your organization type, population, target market, models of interest, expected volume and desired timing. Include your clinical and procurement contacts if identified. Please do not send patient-identifiable health information through the initial enquiry.

Let’s build the right fit

Start with your population. Build from there.

Tell us what your organization wants to improve. We can help you identify the relevant devices, evidence and partnership questions for a focused first conversation.

Contact Us